Susan A. Melin

1.6k total citations
35 papers, 1.1k citations indexed

About

Susan A. Melin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Susan A. Melin has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Susan A. Melin's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Susan A. Melin is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Susan A. Melin collaborates with scholars based in United States, France and India. Susan A. Melin's co-authors include Ralph B. D’Agostino, Julia Lawrence, Frank M. Torti, William C. Little, Craig A. Hamilton, Leslie R. Ellis, Hope S. Rugo, A. William Blackstock, Edward A. Levine and Jennifer H. Jordan and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Susan A. Melin

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan A. Melin United States 17 382 375 280 258 214 35 1.1k
Fabian A. Mendoza United States 17 73 0.2× 88 0.2× 125 0.4× 399 1.5× 153 0.7× 36 1.2k
Apostolos Kontzias United States 15 244 0.6× 355 0.9× 43 0.2× 70 0.3× 127 0.6× 31 1.3k
Jun Hashimoto Japan 16 118 0.3× 377 1.0× 343 1.2× 154 0.6× 124 0.6× 65 1.4k
Atif Hussein United States 18 52 0.1× 311 0.8× 24 0.1× 221 0.9× 170 0.8× 59 829
Julie Yu Canada 15 69 0.2× 245 0.7× 69 0.2× 113 0.4× 200 0.9× 31 1.0k
O Schweisguth France 19 82 0.2× 245 0.7× 106 0.4× 392 1.5× 274 1.3× 79 1.3k
Hisami Iri Japan 22 104 0.3× 229 0.6× 47 0.2× 451 1.7× 339 1.6× 50 1.2k
Polly Niravath United States 14 27 0.1× 456 1.2× 58 0.2× 209 0.8× 65 0.3× 53 970
B Unsgaard Sweden 15 51 0.1× 408 1.1× 140 0.5× 261 1.0× 409 1.9× 25 1.1k
Donata Villari Italy 19 64 0.2× 180 0.5× 62 0.2× 331 1.3× 286 1.3× 65 1.2k

Countries citing papers authored by Susan A. Melin

Since Specialization
Citations

This map shows the geographic impact of Susan A. Melin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan A. Melin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan A. Melin more than expected).

Fields of papers citing papers by Susan A. Melin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan A. Melin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan A. Melin. The network helps show where Susan A. Melin may publish in the future.

Co-authorship network of co-authors of Susan A. Melin

This figure shows the co-authorship network connecting the top 25 collaborators of Susan A. Melin. A scholar is included among the top collaborators of Susan A. Melin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan A. Melin. Susan A. Melin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levine, Beverly J., Susan A. Melin, Carolyn J. Park, et al.. (2024). Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer. Clinical Breast Cancer. 24(4). e289–e296. 2 indexed citations
2.
Jordan, Jennifer H., Ralph B. D’Agostino, Susan A. Melin, et al.. (2021). Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor. JNCI Cancer Spectrum. 5(4). 6 indexed citations
3.
Thomas, Alexandra, Anthony Rhoads, Kristin M. Conway, et al.. (2020). Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016. Clinical Breast Cancer. 20(4). e410–e422. 7 indexed citations
4.
Krok‐Schoen, Jessica L., Michelle J. Naughton, Gregory Young, et al.. (2019). Increasing Adherence to Adjuvant Hormone Therapy Among Patients With Breast Cancer: A Smart Phone App-Based Pilot Study. Cancer Control. 26(1). 1147318551–1147318551. 23 indexed citations
5.
Rugo, Hope S., Susan A. Melin, & Jeffrey Voigt. (2017). Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Research and Treatment. 163(2). 199–205. 51 indexed citations
6.
Lawrence, Julia, et al.. (2014). Does Age Predict Outcome in Patients with Inflammatory Breast Cancer?. The American Surgeon. 80(8). 221–224. 1 indexed citations
7.
Lawrence, Julia, Steven A. Akman, Susan A. Melin, L. Douglas Case, & Gary G. Schwartz. (2013). Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer. Cancer Biology & Therapy. 14(6). 476–480. 19 indexed citations
8.
Drafts, Brandon C., Ralph B. D’Agostino, Julia Lawrence, et al.. (2013). Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease. JACC. Cardiovascular imaging. 6(8). 877–885. 280 indexed citations
9.
Howard-McNatt, Marissa, Julia Lawrence, Susan A. Melin, et al.. (2013). Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer. The American Journal of Surgery. 205(4). 397–401. 7 indexed citations
10.
Glencer, Alexa, Michelle Melisko, L. Esserman, Susan A. Melin, & H. S. Rugo. (2011). Clinical performance, efficacy, and safety of the DigniCap system, a scalp-hypothermia system, in preventing chemotherapy (CTX)-induced alopecia in patients (pts) with early-stage breast cancer (BC).. Journal of Clinical Oncology. 29(15_suppl). TPS244–TPS244. 1 indexed citations
11.
Akman, Sezin Aşık, et al.. (2011). Oral paricalcitol (19-nor-1,25-Dihydroxyvitamn D2) in women with metastatic breast cancer receiving taxanes or ixabepilone: A feasibility trial.. Journal of Clinical Oncology. 29(15_suppl). 1120–1120. 2 indexed citations
12.
Chaosuwannakit, Narumol, Ralph B. D’Agostino, Craig A. Hamilton, et al.. (2009). Aortic Stiffness Increases Upon Receipt of Anthracycline Chemotherapy. Journal of Clinical Oncology. 28(1). 166–172. 112 indexed citations
13.
Ramanathan, Ramesh K., Joel Picus, H. Raftopoulos, et al.. (2007). A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 61(3). 453–458. 24 indexed citations
14.
Miller, Antonius A., Doug Case, Paul D. Savage, et al.. (2007). Phase I Study of Lenalidomide in Solid Tumors. Journal of Thoracic Oncology. 2(5). 445–449. 21 indexed citations
15.
Blackstock, A. William, James Lovato, Michael Farmer, et al.. (2006). Pathologic Complete Response May Not Represent the Optimal Surrogate for Survival After Preoperative Therapy for Esophageal Cancer. International Journal of Gastrointestinal Cancer. 37(1). 7–14. 5 indexed citations
16.
Blackstock, A. William, F. Mornex, Christian Partensky, et al.. (2006). Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. British Journal of Cancer. 95(3). 260–265. 23 indexed citations
17.
Blackstock, A. William, Michael Farmer, James Lovato, et al.. (2005). A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer. International Journal of Radiation Oncology*Biology*Physics. 64(2). 455–460. 27 indexed citations
18.
Mishra, Girish, J.M. Butler, Coty Ho, et al.. (2005). Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 28(4). 345–350. 34 indexed citations
19.
Melin, Susan A., et al.. (2002). Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study. BMC Cancer. 2(1). 9–9. 10 indexed citations
20.
Melin, Susan A., Thomas A. Adamec, B. Hugh Dorman, et al.. (1982). Monolayer culture of human endometrium: Methods of culture and identification of cell types. In Vitro Cellular & Developmental Biology - Plant. 18(11). 911–918. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabian A. Mendoza Breakdown of academic impact, for papers by Apostolos Kontzias Breakdown of academic impact, for papers by Jun Hashimoto Breakdown of academic impact, for papers by Atif Hussein Breakdown of academic impact, for papers by Julie Yu Breakdown of academic impact, for papers by O Schweisguth Breakdown of academic impact, for papers by Hisami Iri Breakdown of academic impact, for papers by Polly Niravath Breakdown of academic impact, for papers by B Unsgaard Breakdown of academic impact, for papers by Donata Villari
Rankless by CCL
2026